Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of imaging in esophageal cancer management in 2020: Update for radiologists
    Review

    Jayaprakasam, V. S.; Yeh, R.; Ku, G. Y.; Petkovska, I.; Fuqua, J. L. 3rd; Gollub, M.; Paroder, V.
    American Journal of Roentgenology (2020)

    Fulltext@MSK | Save
  • Adverse events (AEs) with maintenance olaparib in patients with a germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer (mPaC): Phase III POLO trial
    Meeting Abstract

    Algul, H.; Reni, M.; Kindler, H. L.; Hammel, P.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Pancreatic cancer (PaC)-specific health-related quality of life (HRQoL) with maintenance olaparib (O) in patients (pts) with metastatic (m) PaC and a germline BRCA mutation (gBRCAm): Phase III POLO trial
    Meeting Abstract

    Arnold, D.; Hall, M. J.; Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Park, J. O.; Hochhauser, D.; Oh, D. Y.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Early progression in patients (pts) with metastatic pancreatic cancer (mPaC) and a germline BRCA mutation (gBRCAm): Phase III POLO trial of olaparib (O) vs placebo (P)
    Meeting Abstract

    Reinacher-Schick, A.; Macarulla, T.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Clinical activity of cabozantinib in patients with advanced hepatocellular carcinoma previously treated with anti-VEGF and immuno-oncology therapy: Subgroup analysis from the phase 3 CELESTIAL trial
    Meeting Abstract

    Trojan, J.; Abou-Alfa, G. K.; Cheng, A. L.; Saletan, S.; Kelley, R. K.; El-Khoueiry, A. B.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Multicycle pretargeted radioimmunotherapy using 177(Lu) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; Punzalan, B.; Veach, D.; Xu, H.; Guo, H. F.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted radioimmunotherapy using 225(Ac) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; McDevitt, M.; Xu, H.; Guo, H. F.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer (CRC): An analysis of 18,399 patients in the ARCAD database
    Meeting Abstract

    Wagner, A. D.; Rakez, M.; Chibaudel, B.; Adams, R.; Zalcberg, J. R.; Saltz, L. B.; Venook, A. P.; Schmoll, H. J.; Douillard, J. Y.; Tournigand, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical value of atezolizumab plus bevacizumab for first-line unresectable hepatocellular carcinoma (HCC): A network meta-analysis
    Meeting Abstract

    Vogel, A.; Rimassa, L.; Sun, H. C.; Abou-Alfa, G. K.; El-Khoueiry, A. B.; Pinato, D. J.; Daigl, M.; Alvarez, J. S.; Orfanos, P.; Leibfried, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Effect of video-based patient education on pancreatic cancer knowledge and behavior
    Meeting Abstract

    Turell, W.; Ackbarali, T.; O'Reilly, E. M.; Alsante, M.; Pucci, K.; Del Nido, E. A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save